Average Co-Inventor Count = 2.81
ph-index = 15
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Eli Lilly and Company (97 from 4,446 patents)
2. Eli Lilly Company (2 from 10 patents)
3. Other (1 from 832,843 patents)
4. Eli Lilly (1 from 1 patent)
101 patents:
1. 8962654 - [object Object]
2. 8420654 - 1,5-Diphenyl-pyrrolidin-2-one compounds as CB-1 ligands
3. 8299061 - Inhibitors of diacylglycerol acyltransferase
4. 8202873 - 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines as 5-HT7 receptor antagonists
5. 8168659 - 1, 5-diphenyl-3-benzylamino-1, 5-dihydropyrrolidin-2-one as CB1 receptor modulators
6. 8044090 - N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor
7. 7998985 - 1,5-diphenyl-3-pyridinylamino-1,5-dihydropyrrolidin-2-one as CB1 receptor modulator
8. 7384934 - Piperazine substituted aryl benzodiazepines
9. 7314937 - Non-imidazole aryl alkylamines compounds as histamine H3 receptor antagonists, preparation and therapeutic uses
10. 7230011 - [object Object]
11. 7214673 - Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
12. 7157488 - [object Object]
13. 6864262 - 1-(2-m-methanesulfonamidophenylethyl)-4-(m-trifluoromethylphenyl) piperazine and pharmaceutically acceptable salts and solvents thereof
14. 6777428 - 5-HT1f agonist
15. 6608079 - Indole derivatives and their use as 5-HT1F agonists